Health Condition 1: F06- Other mental disorders due to known physiological condition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Willingness to participate in the study 2 Age 55 years and above 3 Diagnosed with Mild Neurocognitive disorder as per DSM5 criteria
Exclusion criteria
Exclusion criteria: 1 Uncooperative patients or sensory deficits making assessment difficult 2 Refusal to give written informed consent for participation in the study and tDCS application 3 Medical comorbidities that need immediate attention or patients with terminal illness 4 Family or personal history of epilepsy 5 Any contraindication to tDCS such as History of Head injury or Implanted medical devices or Foreign body in head or eye 6 Scalp Injuries or Skin lesions 7 Presence of psychotic symptoms or suicidal ideations 8 Patients currently in Depression with HAMD score greater than 8 or in Delirium 9 Any other psychiatric comorbidity with exception to tobacco use disorder 10 Patients on procognitive drugs like donepezil or memantine etcectra 11 Current use of other neurostimulation treatments 12 Participants with abnormal thyroid function test or serum Vit B 12 level or Vit D3 level
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in cognitive function assessed by ACE-HTimepoint: At End of 1st week, 2nd week, 3rd week | — |
Secondary
| Measure | Time frame |
|---|---|
| - ACE-H (total score) -Change in well-being WHO-Qol-Brief score -Side effect of tDCS Timepoint: At End of 1st week, 2nd week, 3rd week | — |
Countries
India
Contacts
King george medical University